Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by pennyDoctoron Sep 24, 2013 11:00am

90 Views

Post# 21763009

RE:RE:Scotia 85- selling and crosstrading????????????

Good point. Not only Scotia but TD had its hand in the crossing this am.
If you see a lower price not traded to it is usually a cross to trade that lower price to trips some stop loss orders each time. The leader is usually the cross.
Why are we playing with stops at this point? You will have to buy back at higher prices usually as these crooks have sophisticated trading platforms and can see your stops.

Bullboard Posts

A Look into the Future of Chronic Pain Management